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ttp://dx.doi.org/10.1016/j.ajpath.2013.02.016The ﬁve subunits of transcription factor NF-kB have distinct biological functions. NF-kB signaling is
important for skin homeostasis and aging, but the contribution of individual subunits to normal skin
biology and disease is unclear. Immunohistochemical analysis of the p50 and c-Rel subunits within
lesional psoriatic and systemic sclerosis skin revealed abnormal epidermal expression patterns,
compared with healthy skin, but RelA distribution was unaltered. The skin of Nfkb1/ and c-Rel/
mice is structurally normal, but epidermal thickness and proliferation are signiﬁcantly reduced,
compared with wild-type mice. We show that the primary defect in both Nfkb1/ and c-Rel/ mice is
within keratinocytes that display reduced proliferation both in vitro and in vivo. However, both
genotypes can respond to proliferative stress, with 12-O-tetradecanoylphorbol-13-acetateeinduced
epidermal hyperproliferation and closure rates of full-thickness skin wounds being equivalent to those
of wild-type controls. In a model of bleomycin-induced skin ﬁbrosis, Nfkb1/ and c-Rel/ mice
displayed opposite phenotypes, with c-Rel/ mice being protected and Nfkb1/ developing more
ﬁbrosis than wild-type mice. Taken together, our data reveal a role for p50 and c-Rel in regulating
epidermal proliferation and homeostasis and a proﬁbrogenic role for c-Rel in the skin, and identify
a link between epidermal c-Rel expression and systemic sclerosis. Modulating the actions of these
subunits could be beneﬁcial for treating hyperproliferative or ﬁbrogenic diseases of the skin.
(Am J Pathol 2013, 182: 2109e2120; http://dx.doi.org/10.1016/j.ajpath.2013.02.016)Supported by the Institute of Cellular Medicine/Medical Research
Council and the Gerald Kerkut Charitable Trust (N.F.), the Medical
Research Council New Investigator Research Grant G0900535 (F.O.), the
Wellcome Trust WT084961MA (D.A.M.), the European Union FP7 pro-
gramme ‘INFLA-CARE’ (EC contract 223151), and the Biomedical
Research Centre (F.O., D.A.M.).The NF-kB transcription factor family regulates a large
number of genes involved in a range of cellular processes
that include inﬂammation, cell cycle, cell survival, and
matrix turnover. The ﬁve NF-kB subunits are RelA (p65),
RelB, c-Rel, p50, and p52, and these fall into two categories.
Class 1 comprises p50 and p52 (encoded by the genes Nfkb1
and Nfkb2, respectively), which are synthesized as precursor
proteins p105 and p100, respectively; the class 2 subunits
RelA, RelB, and c-Rel are synthesized in an active form.
The subunits form both homo- and heterodimers, which are
held in the cytoplasm in an inactive form by inhibitor of kB
(IkB) protein.1 In the canonical NF-kB pathway, appropriate
stimulation (eg, by IL-1 or TNF-a) induces activation of the
IKK complex. IKK then phosphorylates IkBa, targeting it
for proteasomal degradation and allowing free NF-kB to
translocate to the nucleus and regulate target genes.1
NF-kB signaling is important for normal skin physiology,
and deregulation of this pathway is implicated in disease.2stigative Pathology.
.Psoriasis is a chronic inﬂammatory skin disease, character-
ized by epidermal hyperproliferation and inﬂammation that
result inwell-deﬁned scaly plaques.AberrantNF-kBsignaling
in immune cells and keratinocytes in psoriatic disease has been
described, with evidence of constitutively active NF-kB in
both nonlesional and lesional psoriatic skin.3 A genome-wide
association study strengthened this link, with single-
nucleotide polymorphisms in the Rel gene (synonym: c-Rel )
being associated with psoriasis.4,5 That study also identiﬁed
NFKBIA (the gene encoding IkBa; synonyms: IKBA,MAD3,
and NFKBI ) as a risk factor; however, it is important to note
Fullard et althat this gene can activate or repress NF-kB activity,
depending on whether the mutation increases or decreases the
expression or activity of this inhibitory protein. Moreover,
recent work has identiﬁed rare gain-of-function mutations in
the caspase recruitment domain-containing protein 14
(CARD14) as a cause of psoriasis and CARD14 as the gene
responsible for the psoriasis susceptibility phenotype locus 2
(PSORS2).6,7 CARD14 can activate NF-kB and is highly
expressed in normal epidermis, but displays abnormal
expression in lesional psoriatic epidermis. CARD14 inhibits
apoptosis, which is consistent with the reduced propensity of
psoriatic epidermis to proapoptotic stimuli.
Studies using IKKa or IkB knockout mice (which exhibit
complete loss or constitutive NF-kB activation, respec-
tively) to investigate skin biology have identiﬁed NF-kB as
a master regulator of epidermal homeostasis. Both IKKa
and IkBa knockout mice display epidermal hyperplasia and
atypical differentiation, with increased expression of the
basal and early differentiation markers keratin 14 (K14) and
K10, and a reduction in the late differentiation markers
loricrin and ﬁlaggrin.8e11 Humans with mutations in the
noncatalytic IKK subunit IKK-g [synonym: NF-kB essen-
tial modulator (NEMO)], develop the X-linked skin disease
incontinentia pigmenti.12 Mice lacking NEMO are em-
bryonic lethal, but female heterozygous mice develop a
phenotype similar to incontinentia pigmenti.13,14
The IKKs have targets also outside the NF-kB system,1 and
pan-blockade of this pathway fails to appreciate the diverse
roles of the individual NF-kB subunits in epidermal homeo-
stasis. This diversity has been addressed in normal skin
biology and disease, but some questions remain unanswered.
A role for p50 in epidermal homeostasis was highlighted in
a study using IkBa knockout and IkBa/p50 double-knockout
mice. IkBa knockout mice die from widespread dermatitis,
whereas IkBa/p50 double-knockout mice develop less severe
disease, which suggests that p50 deletion partially rescues the
hyperproliferative skin phenotype.9 Conversely, Seitz et al15
showed that mice expressing a constitutively active p50
under the control of the K14 promoter present with a pheno-
type of epidermal hypoplasia; the authors further implicated
p50 in this process, because p105/p50 shows strong cyto-
plasmic expression in basal cells and moves to the nucleus in
the suprabasal cells. In human keratinocytes, overexpression
of RelA, p50, or c-Rel reduced cell growth and induced
a program of terminal differentiation.16
Both c-Rel and p50 are implicated as key regulators of
epidermal differentiation, although work to date has focused
mainly on pan-blockade of canonical NF-kB signaling,
subunit overexpression, or epidermal targeting of dominant
negative proteins. In the present study, we used c-Rel/
and Nfkb1/ mice to further elucidate the role of these
proteins in skin homeostasis and stress responses. These
mice17,18 develop normally, with no signs of gross
epidermal defects such as those seen in Relb/ mice,19 and
they therefore provide an excellent system for studying the
role of these subunits in normal skin biology and in disease.2110Here, we report abnormal expression of p50 and c-Rel in
both psoriatic skin and skin from systemic sclerosis (SSc)
patients; c-Rel/ andNfkb1/mice were used to dissect the
role of these subunits in normal skin physiology and in
disease. Although both subunits contribute to basal kerati-
nocyte proliferation, they are not essential for 12-O-tetrade-
canoylphorbol-13-acetate (TPA)einduced proliferation or
for normal wound healing. Given the atypical expression
patterns of p50 and c-Rel in SSc, and previous work
describing c-Rel as a proﬁbrogenic factor in the heart and liver
and p105/p50 as a negative regulator of liver ﬁbrosis,20e22
we used a bleomycin skin ﬁbrosis model to elucidate the
roles of p50 and c-Rel in skin ﬁbrosis. In accord with reported
ﬁndings in liver and heart,20e22 ﬁbrogenesis was signiﬁcantly
reduced in c-Rel/mice, whereas Nfkb1/mice developed
more ﬁbrosis, compared with wild-type (WT) mice. These
data suggest that targeting c-Rel or its downstream targets
may be of relevance for the treatment of SSc.
Materials and Methods
Ethics Statement
Animal experiments were approved by the local ethical
review committee and were performed under a United
Kingdom Home Ofﬁce license. Human normal skin, psori-
atic skin, and SSc skin samples were taken under full ethical
approval and with patient consent (REC references JLR/
NJR Min ref: 95/72 and 09/H0905/11).
Mouse Strains and Models
Wild-type, Nfkb1/, and c-Rel/ mice on a pure C57BL/6
background were from Jorge Caamano (Birmingham
University, Birmingham, UK). Adult male mice, 8 to 10
weeks old, were used for experimental models.
Full-Thickness Wounding
Two 6-mm punch wounds were made with sterile dermal
biopsy punches on shaved backskin. Wounds were
measured daily with calipers, and samples were harvested at
1, 3, 5, 7, and 10 days after wounding.
TPA Model
For the TPA model, mice were shaved and treated with
depilatory cream; 24 hours later, either 200 mL of 50 mg/mL
of TPA (Sigma, Poole, UK) in acetone or acetone alone
(vehicle) was applied to the backskin. Mice were sacriﬁced
72 hours after treatment.
Bleomycin Model
For the bleomycin model, mice were anesthetized with
isoﬂurane, their backs were shaved, and 100 mL 0.5 mg/mL
bleomycin (Appollo Scientiﬁc, Cheshire, UK) in salineajp.amjpathol.org - The American Journal of Pathology
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via subcutaneous injection to an area approximately 1 cm2.
Injections were repeated every other day for 4 weeks, at
which point mice were sacriﬁced.23
Barrier Function Assay
The assay was performed as described by Hardman et al.24
In brief, 1-day-old neonatal mice were sacriﬁced via ket-
amine overdose. Mice were washed for 1 minute in an
increasing methanol series of 25%, 50%, 75%, and 100%.
Mice were equilibrated in PBS, stained with 0.2% Toluidine
Blue for 5 minutes, and then washed in water and destained
with 90% ethanol.
Cell Culture
Either primary cells (passage 0) or keratinocyte cell lines
(passage >10) were produced and cultured as described
previously,25 with three mice pooled per cell line. Kerati-
nocytes were cultured with or without 3T3-J2 feeder ﬁbro-
blasts in low-calcium FAD medium (ie, Dulbecco’s
modiﬁed Eagle’s mediumeHam’s F12 medium, 3.5:1.1,
with 0.05 mmol/L Ca2þ, 10% fetal calf serum treated with 2
g Chelex 100 per 50 mL serum 4C overnight, 0.18 mmol/L
adenine, 0.5 mg/mL hydrocortisone, 5 mg/mL insulin, 1010
mol/L cholera toxin, 10 ng/mL epidermal growth factor, 2
mmol/L glutamine, 100 U/mL penicillin, and 100 mg/mL
streptomycin) and maintained at 32C in a 5%
CO2eenriched atmosphere. Primary murine skin ﬁbroblasts
were isolated by outgrowth from biopsies of adult mouse
backskin and were used at passage 9 to 12. Cells were
cultured in Dulbecco’s modiﬁed Eagle’s medium with 10%
fetal calf serum, 2 mmol/L glutamine, 100 U/mL penicillin,
and 100 mg/mL streptomycin and were maintained at 37C
in a 5% CO2eenriched atmosphere.
Proliferation Assay
Keratinocytes were seeded into collagen I-coated 96-well
plates at a density of 5000 cells per well, 4 hours before
addition of 0.11 MBq [3H]thymidine. Keratinocytes were
incubated at 32C in a 5% CO2eenriched atmosphere for
24 hours. Cells were harvested onto printed glass ﬁlter-
mats (Wallac; PerkinElmer, Waltham, MA) using a cell
harvester (Packard Micromate 196; PerkinElmer) and
counted using a liquid scintillation b-counter (MicroBeta
Trilux; PerkinElmer).
Clonogenic Assay
Keratinocytes were seeded at a density of 200 cells/60 cm2
onto a layer of mitomycin Cetreated 3T3 ﬁbroblasts and
were grown for 12 days. Cells were ﬁxed in 10% PBS-
buffered formalin for 10 minutes and were stained with
0.1% crystal violet for 10 minutes. Colonies were visualizedThe American Journal of Pathology - ajp.amjpathol.orgunder a microscope and scored as holoclone, meroclone, or
paraclone, using parameters described previously.26,27
Calcium Differentiation
Keratinocytes were seeded in low-calcium (0.05 mmol/L)
FAD. When conﬂuent monolayers formed, the medium was
changed to high-calcium (1.2 mmol/L) FAD, and cells were
cultured for 7 days, with the medium changed every 2 days.
Scratch Wound Assay
Keratinocytes were grown to a conﬂuent monolayer and
were treated with mitomycin C for 2 hours before genera-
tion of a 1.2-mm scratch. Keratinocytes were then moni-
tored for up to 24 hours.
Western Blotting
3T3-J2 ﬁbroblasts were selectively removed from kerati-
nocyte cultures via trypsin incubation for 2 minutes, 37C.
Keratinocytes were washed with PBS, then lysed in
Laemmli buffer. Neonatal mice were sacriﬁced and placed
in 65C water for 55 seconds; head and limbs were
removed, and epidermis was peeled away. Epidermis was
snap-frozen and ground in liquid nitrogen before lysis with
Laemmli buffer. Whole skin was placed into Laemmli
buffer preheated to 95C; frozen tissue sample was added
to 1 mL buffer and immediately homogenized using
a Polytron homogenizer (Kinematica, Lucerne, Switzerland)
for 1 minute. Samples were transferred to an Eppendorf tube
and were heated to 95C (10 minutes), sonicated, and
centrifuged for 30 minutes at 10,000  g. Protein (15 to 30
mg) was resolved on 9% SDS-polyacrylamide gels. Protein
was transferred onto nitrocellulose membrane. Membranes
were blocked for 45 minutes at room temperature with 3%
nonfat milk powder in Tris-buffered salineeTween. Unless
stated otherwise, primary antibodies were raised in rabbit,
used at 1:1000 dilution, and incubated overnight at 4C. The
following antibodies were used: K1 or K5 (1:1500), ﬁlag-
grin (1:800; Covance, Princeton, NJ), p21 (1:300), p105/
p50, cyclin A (1:200), and GAPDH (1:2000) (Abcam,
Cambridge, UK), mouse antieb-actin (Sigma-Aldrich,
Gillingham, UK; St. Louis, MO), goat anti-p27 (1:300),
RelB or c-Rel (Santa Cruz Biotechnology, Santa Cruz, CA),
mouse antiecyclin D (BD Pharmingen), mouse antiecyclin E
(HE12; Cell Signaling Technology, Danvers, MA), p100/
p52 (EMD Millipore, Billerica, MA), and mouse anti-RelA
(Calbiochem; EMD Millipore). After washing, membranes
were incubated at room temperature for 1 hour with
horseradish peroxidase (HRP) conjugated rabbit anti-goat
(Santa Cruz Biotechnology), goat anti-mouse or goat anti-
rabbit (Sigma-Aldrich) diluted 1:5000 in Tris-buffered sal-
ineeTween. Antigens were visualized using enhanced
chemiluminescence (Amersham ECL; GE Healthcare, Little
Chalfont, UK).2111
Fullard et alRNA Isolation, cDNA Synthesis, and RT-PCR
Frozen tissue sample was added to 1 mL lysis buffer (Buffer
RLT, RNeasy kit; Qiagen, Valencia, CA) and homogenized
using a Polytron homogenizer (Kinematica) for 1minute. RNA
extraction was performed according to the manufacturer’s
instructions. RNA was treated with 1 mL DNase (Promega,
Madison, WI) for 30 minutes at 37C and ﬁrst-strand cDNA
was produced via incubation with random hexamer primer
[p(dN)6] and 100 units Moloney Murine Leukemia Virus
Reverse Transcriptase (Promega, United Kingdom), as
described previously.22 RT-PCR was performed with SYBR
Green JumpStart Taq ready mix (Sigma-Aldrich) according
to the manufacturer’s instructions. The mouse primer
sequences GAPDH forward 50-CACAGTCAAGGCCGA-
GAAT-30 and reverse 50-GCCTTCTCCATGGTGGTGAA-
30, RANTES forward 50-TGCTGCTTTGCCTACCTCTCC-
30 and reverse 50-TGGCAC-ACACTTGGCGGTTCC-30,
and MCP-1 forward 50-AGGTCCCTGTCATGCTTCTG-30
and reverse 50-TCTGGACCCATTCCTTCTTG-30 have an
annealing temperature of 55C. The murine primers TGF-b1
forward 50-CTCCCGTGGCTTCTAGTGC-30 and reverse
50-CCTTAGTTTGGACAGGATCTG-30 and KC forward
50-CTGGGATTCACCTCAAGAACATC-30 and reverse
50-CAGG-GTCAAGGCAAGCCTC-30 have an annealing
temperature of 60C. Mouse Col1a1, Col1a2, and TIMP-1
primers were as described previously.23,28
Histology and Immunohistochemistry
Deparafﬁnized and dehydrated sections were incubated in
2% hydrogen peroxide/methanol for 15 minutes. Trypsin
antigen retrieval was performed at 37C for 25 minutes.
Sections were blocked with avidin/biotin (SP-2001; Vector
Laboratories, Burlingame, CA) for 20 minutes, then with
20% pig serum in PBS for 30 minutes. Slides were incu-
bated overnight at 4C with rabbit primary antibodies
directed against K1 or K5 diluted 1:1500, ﬁlaggrin diluted
1:800 (Covance); p105/p50, RelA, PCNA diluted 1:100
(Abcam); RelA-P-Ser536 diluted 1:100 (Cell Signaling);
and c-Rel diluted 1:100 (Santa Cruz Biotechnology) in 5%
pig serum PBS. Slides were washed with PBS and were
incubated with biotinylated swine anti-rabbit (E0353; Dako,
Glostrup, Denmark) for 1 hour. Ampliﬁcation of antigen
was achieved using an R.T.U. Vectastain kit (Vector
Laboratories), and positive cells were visualized by 3,3-
diaminobenzidine tetrahydrochloride. Sirius Red and H&E
staining were performed according to standard protocols.
Neutrophils were stained using a naphthol AS-D chlor-
oacetate (speciﬁc esterase) kit (Sigma-Aldrich).
Immunoﬂuorescence
Cryosections (5 mm thick) of mouse skin were ﬁxed in
precooled acetone (20C) for 10 minutes and washed with
PBS. Antibodies were diluted in PBS containing 10%2112bovine serum albumin, 0.5% Tween 20, and 0.5% Triton-X-
100. Sections were incubated with rabbit primary antibodies
directed against K1 or K5 diluted 1:1500 or ﬁlaggrin diluted
1:800 (Covance) for 1 hour, washed with PBS, and then
incubated for 1 hour with goat anti-rabbit A594 (Life
TechnologieseInvitrogen, Carlsbad, CA) secondary anti-
body. Slides were washed with PBS and mounted using
aqueous mounting medium with DAPI (H-1200; Vector
Laboratories). Fluorescent images were captured using
a Zeiss Axio Imager Z2 microscope (Carl Zeiss Microscopy,
Jena, Germany).
Epidermal and Dermal Measurements
Photomicrographs of H&E-stained (epidermal) or Sirius
Redestained (dermal) age-matched skin sections were
captured using a Leica DMR microscope equipped with
a DFC 310 FX camera (Leica Microsystems, Wetzlar,
Germany). Thirty epidermal measurements (from basement
membrane to the start of the stratum corneum) were made,
all in interfollicular spaces, and 50 dermal measurements
(from the top of the hypodermis to the start of the epidermis)
were made per mouse, using ImageJ software version 1.47k
(NIH, Bethesda, MD).
Dermal Collagen Area and Density
Immunoﬂuorescence images were captured of Sirius
Redestained skin sections under a rhodamine ﬁlter. Digital
gain was set to zero, with constant exposure. Sirius Rede
stained area and integrated density were calculated using NIH
ImageJ software in ﬁve ﬁelds (100 magniﬁcation).
Statistical Analysis
One-way analysis of variance with Tukey’s post hoc test
was calculated using GraphPad Prism software version 5
(GraphPad Software, San Diego, CA). A P value of <0.05
was considered statistically signiﬁcant.
Results
Localization of Canonical NF-kB Subunits Is Atypical in
Psoriatic and SSc Skin
NF-kB is a critical regulator of inﬂammatory and prolifer-
ative responses in multiple organs and canonical NF-kB
signaling is implicated in epidermal homeostasis, psoriasis,3
skin wound healing responses, and aging.29,30 However, the
biological outcome of activating the NF-kB system can vary
greatly, depending on the subunit being activated, stimuli,
and cell type. We used immunohistochemistry to investigate
the distribution of the canonical subunits RelA, p50, and
c-Rel in human skin sections of normal, psoriatic, and
sclerotic skin. In normal human epidermis, expression of
c-Rel is largely absent from the basal layer, with onlyajp.amjpathol.org - The American Journal of Pathology
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p105/p50 show strong nuclear localization in the granular
layers and show both nuclear positive and nuclear negative
cells in the basal and the suprabasal layers. Both cyto-
plasmic and nuclear expression of the p50 and c-Rel
subunits is widespread throughout the suprabasal layer, but
in the granular layer this switches to high cytoplasmic
expression. Conversely, the RelA subunit, although highly
expressed, shows no clear pattern, with frequent nuclear and
cytoplasmic expression throughout all epidermal layers
(Supplemental Figure S1).
We next examined the expression of phosphorylated
RelA (RelA-P-Ser536) which is associated with active
RelA.31 Again, as with RelA, this modiﬁcation was
observed in the nucleus of all layers of the normal epidermis
(Supplemental Figure S1). In diseased skin, the expression
pattern of the p50 and c-Rel subunits is signiﬁcantly altered.
In SSc, c-Rel is nuclear in the basal layer, with strong
cytoplasmic staining in the granular layer, whereas in
lesional psoriasis the nuclear localization of c-Rel is
conﬁned mainly to the basal layers and is patchy but weaker
in the granular layer. In SSc, localization of p50 is mainly
nuclear in the basal layer, with the frequency of nuclear p50
decreasing as cells migrate from the basal to suprabasal and
granular layers. In contrast to normal skin, localization of
p50 is nuclear in all layers of both uninvolved and involved
psoriatic skin (Figure 1). The epidermal expression pattern
of RelA and RelA-P-Ser536 in diseased skin is similar to
that in normal healthy skin, whereas the normal distribution
of both the p50 and c-Rel subunits is drastically altered
under conditions of injury, deregulated proliferation
(psoriasis), and ﬁbrosis (SSc). We therefore investigated the
contribution of these subunits to normal skin physiology
and disease using c-Rel and Nfkb1 (p105/p50) knockout
mice.
Nfkb1/ and c-Rel/ Mice Display Epidermal
Hypoplasia But Have Normal Epidermal Structure
NF-kB is an established regulator of epidermal thickness.
Mutant mice expressing dominant negative IkBa exhibit
epidermal hyperplasia, and mice expressing a constitutively
active form of p50 develop epidermal hypoplasia.15 We
conﬁrmed deletion of p105/p50 and c-Rel subunits in
neonatal skin of Nfkb1/ and c-Rel/ mice by Western
blotting. Importantly, levels of the other NF-kB subunits
were similar to those of WT mice, excluding the possibility
that any phenotypic differences were due to changes in
expression of the remaining subunits (Supplemental
Figure S2A). Thickness measurements taken from Nfkb1/
and c-Rel/mouse backskin revealed a state of epidermal
hypoplasia, with the living epidermal layers of Nfkb1/
and c-Rel/ mice being signiﬁcantly thinner (17% and
20%, respectively) than in age-matched WT controls
(Figure 2A). To assess whether this difference is due to
a proliferative defect within the epidermis, we performedThe American Journal of Pathology - ajp.amjpathol.orgimmunohistochemistry for the proliferation marker PCNA
on the backskin of WT, Nfkb1/, and c-Rel/ mice. Cell
counts revealed a 30% decrease in PCNAþ cells in Nfkb1/
epidermis and a 45% decrease in c-Rel/ epidermis, sug-
gesting that both genotypes had an epidermal proliferative
defect (Figure 2B). Immunoﬂuorescence staining revealed
normal epidermal differentiation and stratiﬁcation, with
similar expression of K5 in the basal layer, K1 in the
suprabasal layer, and ﬁlaggrin in the granular layer of WT,
Nfkb1/, and c-Rel/ mice (Figure 2C). Western blot
analysis conﬁrmed that expression levels of these proteins in
Nfkb1/ and c-Rel/ mice were similar to those of WT
mice (Figure 2D). Similarly, barrier function was not
impaired in these mice, as shown by Toluidine Blue
exclusion in neonatal pups (Supplemental Figure S2B).
Keratinocytes Null for Nfkb1 and c-Rel Differentiate
Normally But Proliferate More Slowly
We derived keratinocyte lines from backskin of WT,
Nfkb1/, and c-Rel/ mice, as described previously,25 to
determine whether keratinocyte differentiation is normal. As
for whole skin, protein expression of all NF-kB subunits
was similar in the keratinocyte lines from WT, Nfkb1/,
and c-Rel/ mice (Supplemental Figure S3A). A clono-
genic assay was used to determine the potential of the
keratinocyte population to differentiate, based on the ability
of these cells to form different types of colony depending on
the properties of the individual cell. Large, highly prolifer-
ative, spherical colonies consisting of small densely packed
cells were identiﬁed as holoclones and derived from stem
cells. Small, nonproliferative, highly irregular colonies that
contained mostly large, ﬂattened cells were classiﬁed as
paraclones. Paraclones are more differentiated, and mer-
oclones display characteristics of both holoclones and para-
clones.26,27 WT, Nfkb1/, and c-Rel/ mouse keratinocyte
cultures exhibited similar ratios of holoclones, meroclones,
and paraclones, conﬁrming normal differentiation capacity
of the keratinocytes in culture (Figure 3A). On culture in
1.2 mmol/L CaCl2, keratinocytes differentiate, with the
number of large, ﬂattened cells increasing and cultures
becoming stratiﬁed. After 7 days in high-calcium conditions,
there was no difference in the expression of K5 and ﬁlaggrin
among the genotypes, but K1 was reduced in Nfkb1/ mice
(Figure 3B). Taken together, these ﬁndings imply that p105/
p50e and c-Reledependent signaling does not affect kera-
tinocyte differentiation.
Although 95% of the epidermis consists of keratino-
cytes,32 the remainder is comprised of other cells, and it is
therefore possible that signals from these other cells could
contribute to the impaired regeneration phenotype. To
investigate whether deletion of p105/p50 or c-Rel suppresses
proliferation of keratinocytes in culture, we performed [3H]
thymidine proliferation assays on our keratinocyte cell lines.
Proliferation was signiﬁcantly reduced in both Nfkb1/ and
c-Rel/ keratinocytes, with [3H]thymidine incorporation at2113
Figure 1 Aberrant expression of canonical NF-kB subunits is associated with human skin disease. Representative photomicrographs of p50 and c-Rel
immunostaining in normal human skin, skin from patients with SSc (scleroderma), and involved and uninvolved areas of skin from psoriasis. Positive nuclei in
the basal layer of p50- and c-Relestained skin are indicated by arrows. The dermoepidermal junction is indicated by a dashed line. nZ 3 (normal); nZ 6
(SSc, uninvolved psoriasis, and involved psoriasis). Scale bars: 100 mm (ﬁrst three rows); 50 mm (last row).
Fullard et al36% and 37% ofWT keratinocytes, respectively (Figure 3C),
revealing that loss of these NF-kB subunits reduces their
intrinsic proliferative potential. Because Nfkb1/ and
c-Rel/mice and keratinocytes display proliferative defects
but normal epidermal differentiation and structure, we
hypothesized that the p105/p50 and c-Rel subunits could
regulate cell-cycle genes. For example, p27 is known to
inhibit the activities of cyclin D and to prevent transition of
cells through G1 into S phase of the cell cycle,33 and p27 up-
regulation is important in keratinocyte differentiation.34
Western blot analysis revealed a modest up-regulation of
the cell-cycle inhibitor p27 in Nfkb1/ cell-line keratino-
cytes (Figure 3D) and primary (passage 0) keratinocytes
(Supplemental Figure S3B). Conversely, levels of cyclin D
and p21, another cell-cycle inhibitor associated with cyclin
D, were unchanged (Figure 3D). Levels of cyclins A, B1, and
E were similar in WT and c-Rel/ keratinocytes, but in
Nfkb1/ keratinocytes there was a small reduction in cyclin
E levels (Figure 3D). These data suggest that elevation of p272114in Nfkb1/ mice may contribute to the proliferative defect;
however, further investigations into the mechanism or
mechanisms regulating cellular proliferation in these cells are
required.
Nfkb1/ and c-Rel/ Mice Respond Normally to
Epidermal Stress
Despite the basal proliferative defect, the epidermis of
Nfkb1/ and c-Rel/mice responds normally to epidermal
stressors and injury. Application of TPA to the backskin of
mice induces epidermal hyperplasia. Both Nfkb1/ and
c-Rel/ mice have reduced epidermal proliferation. We
therefore hypothesized that these mice would fail to respond
to TPA treatment. However, epidermal thickening in response
to TPA was observed in all three genotypes (P< 0.001, WT,
P < 0.01 Nfkb1/ and c-Rel/ (P < 0.01), compared with
acetone vehicleetreated skin. There was a trend toward
increased proliferation, with elevated numbers of PCNAþajp.amjpathol.org - The American Journal of Pathology
Figure 2 Deletion of p105/p50 or c-Rel reduces
epidermal thickness, but normal skin structure is
retained. A: Epidermal thickness is reduced in
Nfkb1/ and c-Rel/ skin (H&E-stained parafﬁn
sections). B: Epidermal proliferation, measured by
PCNA staining of parafﬁn-embedded murine back-
skin, is reduced in Nfkb1/ and c-Rel/. PCNAþ
keratinocytes are indicated by arrows. C: Immuno-
ﬂuorescence for K5, K1, and ﬁlaggrin in murine
backskin (red), with DAPI counterstain (blue).
Basement membrane is indicated by a dashed line.
No differences in expression were observed between
genotypes. D: Western blots of whole epidermal
protein lysates from neonatal mice conﬁrming
absence of p105/p50 and c-Rel subunits inNfkb1/
and c-Rel/ mice, with similar expression levels of
K5, K1 and proﬁlaggrin (PF), intermediates (I), and
ﬁlaggrin (F). Scale bars, 100mm(A andB); 50mm(A,
inset, and C). Data are expressed as means  SEM.
nZ 5 mice per genotype. *P < 0.05, **P < 0.01,
and ***P < 0.001. HPF, high-power ﬁeld.
c-Rel in Skin Biology and Fibrosiscells in WT, Nfkb1/, and c-Rel/ mice treated with TPA,
compared with acetone vehicle treatment (Figure 4B); the
difference reached statistical signiﬁcance in c-Rel/ mice
(P < 0.01). Consistent with the literature, treatment with the
acetone vehicle also stimulated epidermal thickening.35
However, epidermal thickness and PCNAþ cells increased
signiﬁcantly in the acetone-treated c-Rel/ mice, compared
with untreated skin. It is important to note that the skin of
c-Rel/ mice became red and scaly on addition of ace-
tone, suggesting a hypersensitive response to acetone, which
likely contributed to the phenotype observed (Supplemental
Figure S4A).
Wound Healing Responses Are Normal in Nfkb1/ and
c-Rel/ Mice
Clinically, impaired wound healing and closure represent
a massive health-care burden. Here, we report that mice
lacking p105/p50 and c-Rel have reduced proliferation, and
Adler et al36 reported that NF-kB signaling is important for
maintaining what they call a youthful skin phenotype and
epidermal thickness. Furthermore, Melchionna et al29
showed that siRNA knockdown of Rel subunits in HaCaT
human keratinocytes impaired closure of scratch wounds
in vitro. Deregulated NF-kB activity may therefore impair
the closure of full-thickness skin wounds. We performedThe American Journal of Pathology - ajp.amjpathol.org6-mm dual-punch biopsies in WT, Nfkb1/, and c-Rel/
mice and monitored wound closure over 10 days. There was
no difference in the rate of wound healing across the
genotypes (Supplemental Figure S4B). This suggests that
other subunits can compensate for the loss of either p105/
p50 or c-Rel to promote normal keratinocyte proliferation in
situations of stress and that loss of these subunits does not
alter wound contraction or keratinocyte migration. To
address the latter possibility, we performed a scratch-wound
assay on our keratinocyte cell lines. Cells were grown as
a conﬂuent monolayer and then were treated with mito-
mycin C, to prevent cell proliferation and thus allow
measurement of migration alone,37 before scratch wound-
ing. There was no difference in the rate of wound closure
among WT, Nfkb1/, and c-Rel/ keratinocytes in vitro,
suggesting that cell migration is normal and may provide
one explanation for the normal wound healing response
in vivo (Supplemental Figure S4C).
Nfkb1 and c-Rel Have Opposing Roles in Bleomycin-
Induced Skin Fibrosis
SSc is an autoimmune disease characterized by progressive
ﬁbrosis of the skin and other organs.38 Peripheral blood
mononuclear cells from SSc patients show elevated NF-kB
DNA binding at an NF-kB site within the IL-2 promoter,392115
Figure 3 Differentiation is normal, but
regeneration is impaired in Nfkb1/ and c-Rel/
keratinocytes. A: Cultured keratinocytes produce
three types of colonies: holoclones, meroclones,
and paraclones. No difference in proportions of
colony type was observed among WT, Nfkb1/,
and c-Rel/ keratinocytes (passage 20 to 30). B:
Western blots of whole-protein lysates from kera-
tinocyte cell lines show similar expression levels of
K5, K1, and ﬁlaggrin in low-calcium (0.05 mmol/L)
and high-calcium (1.2 mmol/L) medium. C: [3H]
Thymidine incorporation revealed reduced prolif-
eration in Nfkb1/ and c-Rel/ keratinocytes
(passage 20 to 30). D: Western blots show an up-
regulation of p27 in Nfkb1/ and c-Rel/ kera-
tinocytes and reduced expression of cyclin E in
Nfkb1/ keratinocytes, whereas cyclin A, cyclin D,
and p21 expression levels are similar to those in
WT keratinocytes. Data are expressed as means 
SEM. nZ 8. ***P < 0.001. Scale barZ 200 mm.
Fullard et aland a genome-wide association study identiﬁed a single-
nucleotide polymorphism in the Nfkb1 gene that was asso-
ciated with increased susceptibility to SSc.40
We have previously reported that the p50 and c-Rel
subunits have opposing ﬁbrogenic properties in the liver, with
p105/p50 deletion exacerbating ﬁbrosis and c-Rel deletion
being protective.21 The situation is similar in the heart, and c-
Relenull mice develop less cardiac ﬁbrosis20 in response to
chronic angiotensin infusion. Given the aberrant expression
patterns of these subunits in SSc, we performed an in vivo
model of skin ﬁbrosis in our mice. Repeated subcutaneous
administration of bleomycin induces dermal thickening and
ﬁbrosis.23 Dermal thickness was increased in the skin of WT
and Nfkb1/ mice, but deletion of c-Rel conveyed complete
protection (Figure 5A). As predicted from work in the liver,
collagen deposition but not density was greater in bleomycin-
treated Nfkb1/ mice, compared with WT mice; conversely,
collagen deposition was reduced in mice lacking c-Rel
(Figure 5B). The ﬁbrotic phenotype was associated with
a trend toward increased levels of a-SMAþmyoﬁbroblasts in
response to bleomycin in WT and Nfkb1/ mice, with
Nfkb1/ mice exhibiting elevated levels also in control
groups. In c-Rel/ mice, however, the numbers of a-SMAþ
cells were reduced in both control and treatment groups
(Figure 5C and Supplemental Figure S5A). After bleomycin
treatment, mRNA levels of the proﬁbrogenic factor TGF-b1
were elevated in WT and Nfkb1/ mice, but were halved in
c-Rel/ mice (Figure 5C).
c-Relenull mice develop less hepatic ﬁbrosis after toxic or
surgical liver injury, compared with WT controls, and this
was associated with a reduction in collagen gene expression
in c-Reledeﬁcient liver myoﬁbroblasts.21 To ascertain
whether c-Rel regulates the ﬁbrogenic phenotype of skin
ﬁbroblasts, we measured the expression of proﬁbrotic genes
in WT and c-Rel/ skin ﬁbroblasts and found that levels of2116Col1a2, tissue inhibitor of metalloproteinases 1 (TIMP-1),
and TGF-b1 were suppressed in the absence of c-Rel
(Supplemental Figure S6A). Suppression of ﬁbrogenic
genes, including collagen genes, could be one mechanism by
which deletion of c-Rel conveys protection against devel-
opment of skin ﬁbrosis.
Inﬂammation drives ﬁbrosis in multiple organs and
underpins the progression of SSc, and NF-kB is a pivotal
regulator of immune responses.We therefore investigated the
effect of p105/p50 or c-Rel on bleomycin-induced skin
inﬂammation. Neutrophil and CD3þ T-lymphocyte recruit-
ment was higher in WT and Nfkb1/ mice after bleomycin
treatment, compared with vehicle-treated controls, whereas
recruitment of neutrophils and T-cells was similar or reduced
in c-Rel/ mice after bleomycin treatment (Figure 5D and
Supplemental Figure S5A). Levels of the inﬂammatory
chemokines platelet-derived growth factor-inducible protein
KC (KC), RANTES, and MCP-1 were also up-regulated in
WT and Nfkb1/mice after bleomycin treatment, but not in
c-Rel/ mice (Supplemental Figure S6B).
Discussion
The importance of NF-kB in skin homeostasis and disease
pathology is clear,36,41 and genome-wide association studies
have identiﬁed polymorphisms in Rel genes as disease risk
factors in SSc and psoriasis.4,5,40 However, NF-kB signaling
is complex and can invoke both positive and negative
effects on gene expression; this is dependent on many
factors, including dimer subunit composition, cell type or
stimulus, and even the DNA consensus sequence of the kB
site.1 Multiple in vitro and in vivo studies dissecting the role
of NF-kB in skin disease have used mice lacking the
upstream NF-kB regulators IKK or IkB or mice with
multiple combinations of NF-kB subunits and TNFajp.amjpathol.org - The American Journal of Pathology
Figure 4 Skin hyperproliferative responses to
topical TPA are retained in Nfkb1 and c-Rel
knockout mice. A: Application of TPA increases
epidermal thickness over 72 hours, compared with
acetone control, in WT and c-Rel/ mice; the
difference did not reach statistical signiﬁcance in
Nfkb1/ mice. Photomicrographs are representa-
tive of H&E-stained vehicle (acetone) and TPA-
treated skin after 72 hours. B: PCNAþ cells
numbers show a trend of increased proliferation in
response to TPA. Proliferation in c-Rel/
epidermis was signiﬁcantly increased, compared
with WT. PCNAþ keratinocytes are indicated by
arrows. Data are expressed as means  SEM. n Z
5 mice per genotype. *P < 0.05; ***P < 0.001
one-way analysis of variance. Scale barZ 50 mm.
c-Rel in Skin Biology and Fibrosisreceptors deleted.8,9,11,15 Although such work is informative
and validates NF-kB as a target with therapeutic potential,
prolonged global inhibition of this pathway may negatively
affect skin homeostasis, because NF-kB is required for
normal cellular processes, including proliferation and cell
survival. Another consideration is that IKK proteins have
targets outside the NF-kB system.1 Focusing on the
contribution of individual subunits to skin biology and
disease may offer an improved or more speciﬁc targeting
strategy.
In the present study, we used skin samples from SSc and
psoriasis patients and from mice lacking p50 and c-Rel to
assess the role of these proteins in normal skin biology and
disease pathology. We observed aberrant epidermal expres-
sion of the p50 and c-Rel subunits in both SSc and psoriatic
skin samples, suggesting that deregulated NF-kB signaling
may contribute to imbalanced keratinocyte proliferation and
to perpetuation of these disease processes. Indeed, Nfkb1/
and c-Rel/ mice displayed features of epidermal hypo-
plasia, which were associated with reduced keratinocyte
proliferation both in vitro and in vivo. However, the structure
of the epidermis and its ability to respond to chemical stress
and wound healing was normal in these mice. NF-kB acti-
vation promotes keratinocyte survival,41 and therefore anti-
apoptotic pathways may be induced in response to chemical
or mechanical stresses, which may contribute to the hypo-
proliferative phenotype. Nonetheless, these data further
highlight the complexity of NF-kB signaling and suggest thatThe American Journal of Pathology - ajp.amjpathol.orgslowing keratinocyte proliferation or modulating apoptosis
by lowering the activities of these proteins may be beneﬁcial
in hyperproliferative skin diseases such as psoriasis.
SSc is a systemic inﬂammatory disease that causes ﬁbrosis
in multiple organs, including the skin. We used a bleomycin
model to study the inﬂuence of c-Rel and p50 on the devel-
opment of skin ﬁbrosis. The c-Relenull mice did not develop
dermal ﬁbrosis in response to exposure to the chemical irri-
tant bleomycin, whereas mice lacking p105/p50 (Nfkb1/
mice) had an exacerbated ﬁbrotic response, compared with
WT. The protective phenotype of c-Relenull mice was
associated with fewer a-SMAþ myoﬁbroblasts and a reduc-
tion in immune cell inﬁltration, whereas the opposite changes
were observed in mice lacking p105/p50. Our observations in
Nfkb1/ mice are consistent with proinﬂammatory and
ﬁbrogenic phenotypes in other organs, including liver, heart,
and lung, or after inﬂammatory challenge.20e22,42 Interest-
ingly, deletion of c-Rel has now been shown to be antiﬁbrotic
in three different organs, including the heart and liver as well
as skin.20,21 Fibrogenic genes are reduced in c-Relenull liver
myoﬁbroblasts and skin ﬁbroblasts, suggesting that c-Rele
dependent signaling could be a core ﬁbrogenic regulator and
as such may be an attractive antiﬁbrotic target. The c-Rel
subunit also plays a major role in B-cell and T-cell biology,
and is critical for T-reg and Th17 development.43 A recent
study revealed high levels of IL-21R in the epidermis of SSc
patients, and showed that cultured keratinocytes can express
an array of inﬂammatory and ﬁbrogenic cytokines and2117
Figure 5 Deletion of c-Rel but not p105/p50 is
protective in a model of bleomycin-induced skin
ﬁbrosis. A: Dermal measurements and representative
ﬂuorescent images of Sirius Redestained dorsal skin
from bleomycin- and saline controletreated WT,
Nfkb1/, and c-Rel / mice. Bleomycin causes
dermal thickening inWT andNfkb1/mice but not c-
Rel/ mice. B: Mean percent collagen area and
density calculated using image analysis from Sirius
Redestained skin among bleomycin- and saline
controletreated WT, Nfkb1/, and c-Rel/mice. C:
Average dermal myoﬁbroblasts, measured by a-SMA
staining of parafﬁn-embedded murine backskin were
increased in Nfkb1/. Skin TGF-b1 mRNA levels were
up-regulated in bleomycin-treated WT and Nfkb1/
but not c-Rel / mice. D: Average neutrophil and
CD3þ cell counts in bleomycin- and saline controle
treated WT, Nfkb1/, and c-Rel/mice. There was
a trend toward increased CD3þ cells with bleomycin
treatment inWT andNfkb1/ but not c-Rel/mice,
whereas neutrophil inﬁltration was signiﬁcantly
increased in WT andNfkb1/ but not c-Rel /mice.
Data are expressed as means  SEM. n Z 10, WT;
nZ 8, Nfkb1/; nZ 9, c-Rel/. *P< 0.05, **P<
0.01, and ***P < 0.001. Scale barZ 100 mm.
Fullard et alchemokines, including IL-6, MCP-1, and TGF-b1.44 Further
work is needed to dissect the function of c-Rel in immune
cells, ﬁbroblasts, and epithelial cells to ﬁbrogenesis. Equally,
assessing the inﬂuence of dermal and epidermal crosstalk on
disease pathology would be a worthwhile avenue to explore.2118Currently, no small-molecule inhibitors for c-Rel are
available. Strategies for blocking the actions of c-Rel could
instead focus on delivery of siRNA directed against c-Rel or
against ﬁbrogenic genes identiﬁed as downstream targets.
The former is now a realistic option, given that c-Rel siRNAsajp.amjpathol.org - The American Journal of Pathology
c-Rel in Skin Biology and Fibrosishave been developed and successfully used to induce
apoptosis of lymphoma cells.45 An important consideration
in targeting siRNAs to the skin is that skin is designed to be
impermeable, and therefore delivering these agents across the
stratum corneum is a signiﬁcant challenge. However, recent
reports from two independent research groups have described
two separate delivery systems that have been used in vivo to
effectively deliver siRNA across the stratum corneum to cells
within the epidermis and dermis.46,47
Finally, we suggest that modulating or blocking the
actions of p50 and c-Rel could be a novel strategy in the
treatment of the hyperproliferative disease, and that sup-
pressing c-Reledependent transcription in skin ﬁbrosis has
therapeutic potential.
Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2013.02.016.
References
1. Perkins ND: Integrating cell-signalling pathways with NF-kappaB and
IKK function. Nat Rev Mol Cell Biol 2007, 8:49e62
2. Pasparakis M: Role of NF-kappaB in epithelial biology. Immunol Rev
2012, 246:346e358
3. Bell S, Degitz K, Quirling M, Jilg N, Page S, Brand K: Involvement of
NF-kappaB signalling in skin physiology and disease. Cell Signal
2003, 15:1e7
4. Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, et al,
Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case
Control Consortium 2: A genome-wide association study identiﬁes new
psoriasis susceptibility loci and an interaction between HLA-C and
ERAP1. Nat Genet 2010, 42:985e990
5. Stuart PE, Nair RP, Ellinghaus E, Ding J, Tejasvi T, Gudjonsson JE,
Li Y, Weidinger S, Eberlein B, Gieger C, Wichmann HE, Kunz M,
Ike R, Krueger GG, Bowcock AM, Mrowietz U, Lim HW,
Voorhees JJ, Abecasis GR, Weichenthal M, Franke A, Rahman P,
Gladman DD, Elder JT: Genome-wide association analysis identiﬁes
three psoriasis susceptibility loci. Nat Genet 2010, 42:1000e1004
6. Jordan CT, Cao L, Roberson ED, Duan S, Helms CA, Nair RP,
Dufﬁn KC, Stuart PE, Goldgar D, Hayashi G, Olfson EH, Feng BJ,
Pullinger CR, Kane JP, Wise CA, Goldbach-Mansky R, Lowes MA,
Peddle L, Chandran V, Liao W, Rahman P, Krueger GG, Gladman D,
Elder JT, Menter A, Bowcock AM: Rare and common variants in
CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
Am J Hum Genet 2012, 90:796e808
7. Jordan CT, Cao L, Roberson ED, Pierson KC, Yang CF, Joyce CE,
Ryan C, Duan S, Helms CA, Liu Y, Chen Y, McBride AA, Hwu WL,
Wu JY, Chen YT, Menter A, Goldbach-Mansky R, Lowes MA,
Bowcock AM: PSORS2 is due to mutations in CARD14. Am J Hum
Genet 2012, 90:784e795
8. Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt PH,
Chen CH, Rosen CA, Stewart CL: IkappaBalpha deﬁciency results in
a sustained NF-kappaB response and severe widespread dermatitis in
mice. Mol Cell Biol 1996, 16:2341e2349
9. Beg AA, Sha WC, Bronson RT, Baltimore D: Constitutive NF-kappa
B activation, enhanced granulopoiesis, and neonatal lethality in I kappa
B alpha-deﬁcient mice. Genes Dev 1995, 9:2736e2746
10. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC,
Verma IM: IKK1-deﬁcient mice exhibit abnormal development of skin
and skeleton. Genes Dev 1999, 13:1322e1328The American Journal of Pathology - ajp.amjpathol.org11. Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, Kawai T,
Sanjo H, Yoshikawa K, Terada N, Akira S: Limb and skin abnor-
malities in mice lacking IKKalpha. Science 1999, 284:313e316
12. Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A,
Israel A, Heiss NS, Klauck SM, Kioschis P, Wiemann S, Poustka A,
Esposito T, Bardaro T, Gianfrancesco F, Ciccodicola A, D’Urso M,
Woffendin H, Jakins T, Donnai D, Stewart H, Kenwrick SJ,
Aradhya S, Yamagata T, Levy M, Lewis RA, Nelson DL: Genomic
rearrangement in NEMO impairs NF-kappaB activation and is a cause
of incontinentia pigmenti. The International Incontinentia Pigmenti
(IP) Consortium. Nature 2000, 405:466e472
13. Makris C, Godfrey VL, Krähn-Senftleben G, Takahashi T, Roberts JL,
Schwarz T, Feng L, Johnson RS, Karin M: Female mice heterozygous
for IKK gamma/NEMO deﬁciencies develop a dermatopathy similar to
the human X-linked disorder incontinentia pigmenti. Mol Cell 2000, 5:
969e979
14. Schmidt-Supprian M, Bloch W, Courtois G, Addicks K, Israel A,
Rajewsky K, Pasparakis M: NEMO/IKK gamma-deﬁcient mice model
incontinentia pigmenti. Mol Cell 2000, 5:981e992
15. Seitz CS, Lin Q, Deng H, Khavari PA: Alterations in NF-kappa B
function in transgenic epithelial tissue demonstrate a growth inhibitory
role for NF-kappa B. Proc Natl Acad Sci USA 1998, 95:2307e2312
16. Seitz CS, Deng H, Hinata K, Lin Q, Khavari PA: Nuclear factor kappa
B subunits induce epithelial cell growth arrest. Cancer Res 2000, 60:
4085e4092
17. Köntgen F, Grumont RJ, Strasser A, Metcalf D, Li RL, Tarlinton D,
Gerondakis S: Mice lacking the c-Rel protooncogene exhibit defects in
lymphocyte-proliferation, humoral immunity, and interleukin-2 expres-
sion. Genes Dev 1995, 9:1965e1977
18. Sha WC, Liou HC, Tuomanen EI, Baltimore D: Targeted disruption of
the p50 subunit of NF-kappa-B leads to multifocal defects in immune-
responses. Cell 1995, 80:321e330
19. Barton D, HogenEsch H, Weih F: Mice lacking the transcription factor
RelB develop T cell-dependent skin lesions similar to human atopic
dermatitis. Eur J Immunol 2000, 30:2323e2332
20. Gaspar-Pereira S, Fullard N, Townsend P, Banks P, Ellis E, Fox C,
Maxwell A, Murphy L, Kirk A, Bauer R, Caamaño J, Figg N, Foo R,
Mann J, Mann D, Oakley F: The NF-kB subunit c-Rel stimulates
cardiac hypertrophy and ﬁbrosis. Am J Pathol 2012, 180:929e939
21. Gieling RG, Elsharkawy AM, Caamaño JH, Cowie DE, Wright MC,
Ebrahimkhani MR, Burt AD, Mann J, Raychaudhuri P, Liou HC,
Oakley F, Mann DA: The c-Rel subunit of nuclear factor-kappa B
regulates murine liver inﬂammation, wound-healing, and hepatocyte
proliferation. Hepatology 2011, 51:922e931
22. Oakley F, Mann J, Nailard S, Smart DE, Mungalsingh N,
Constandinou C, Ali S, Wilson SJ, Millward-Sadler H, Iredale JP,
Mann DA: Nuclear factor-kappa beta 1 (p50) limits the inﬂammatory
and ﬁbrogenic responses to chronic injury. Am J Pathol 2005, 166:
695e708
23. Palumbo K, Zerr P, Tomcik M, Vollath S, Dees C, Akhmetshina A,
Avouac J, Yaniv M, Distler O, Schett G, Distler JH: The transcription
factor JunD mediates transforming growth factor {beta}-induced
ﬁbroblast activation and ﬁbrosis in systemic sclerosis. Ann Rheum Dis
2011, 70:1320e1326
24. Hardman MJ, Sisi P, Banbury DN, Byrne C: Patterned acquisition of
skin barrier function during development. Development 1998, 125:
1541e1552
25. Reichelt J, Haase I: Establishment of spontaneously immortalized
keratinocyte lines from wild-type and mutant mice. Methods Mol Biol
2010, 585:59e69
26. Barrandon Y, Green H: Three clonal types of keratinocyte with
different capacities for multiplication. Proc Natl Acad Sci USA 1987,
84:2302e2306
27. Vollmers A, Wallace L, Fullard N, Höher T, Alexander MD,
Reichelt J: Two- and three-dimensional culture of keratinocyte stem
and precursor cells derived from primary murine epidermal cultures.
Stem Cell Rev 2012, 8:402e4132119
Fullard et al28. Perugorria MJ, Murphy LB, Fullard N, Chakraborty JB, Vyrla D,
Wilson CL, Oakley F, Mann J, Mann DA: Tumor progression locus
2/Cot is required for activation of extracellular regulated kinase in liver
injury and toll-like receptor-induced TIMP-1 gene transcription in
hepatic stellate cells in mice. Hepatology 2013, 57:123e1249
29. Melchionna R, Bellavia G, Romani M, Straino S, Germani A, Di
Carlo A, Capogrossi MC, Napolitano M: C/EBPgamma regulates
wound repair and EGF receptor signaling. J Invest Dermatol 2012,
132:1908e1917
30. Tilstra JS, Robinson AR, Wang J, Gregg SQ, Clauson CL, Reay DP,
Nasto LA, St Croix CM, Usas A, Vo N, Huard J, Clemens PR, Stolz DB,
Guttridge DC, Watkins SC, Garinis GA, Wang Y, Niedernhofer LJ,
Robbins PD: NF-kappaB inhibition delays DNA damage-induced
senescence and aging in mice. J Clin Invest 2012, 122:2601e2612
31. Moles A, Sanchez AM, Banks PS, Murphy LB, Luli S, Borthwick L,
Fisher A, O’Reilly S, van Laar JM, White SA, Perkins ND, Burt AD,
Mann DA, Oakley F: Inhibition of RelA-Ser536 phosphorylation by
a competing peptide reduces mouse liver ﬁbrosis without blocking the
innate immune response. Hepatology 2013, 57:817e828
32. McGrath JA, Eady RAJ, Pope FM: Anatomy and organization of
human skin. Edited by Burns DA, Breathnach SM, Cox NH,
Grifﬁths CEM. Rook’s Textbook of Dermatology. ed 7. Oxford,
Blackwell Publishing, 2004, pp 3.1e3.6
33. Vermeulen K, Van Bockstaele DR, Berneman ZN: The cell cycle:
a review of regulation, deregulation and therapeutic targets in cancer.
Cell Prolif 2003, 36:131e149
34. Hauser PJ, Agrawal D, Flanagan M, Pledger WJ: The role of p27kip1
in the in vitro differentiation of murine keratinocytes. Cell Growth
Differ 1997, 8:203e211
35. Denda M, Wood LC, Emami S, Calhoun C, Brown BE, Elias PM,
Feingold KR: The epidermal hyperplasia associatedwith repeated barrier
disruption by acetone treatment or tape stripping cannot be attributed to
increased water loss. Arch Dermatol Res 1996, 288:230e238
36. Adler AS, Sinha S, Kawahara TLA, Zhang JY, Segal E, Chang HY:
Motif module map reveals enforcement of aging by continual NF-
kappa B activity. Genes Dev 2007, 21:3244e3257212037. Nishiyama T, Kii I, Kashima TG, Kikuchi Y, Ohazama A,
Shimazaki M, Fukayama M, Kudo A: Delayed re-epithelialization in
periostin-deﬁcient mice during cutaneous wound healing. PLoS One
2011, 6:e18410
38. Jinnin M: Mechanisms of skin ﬁbrosis in systemic sclerosis. J Der-
matol 2010, 37:11e25
39. Becker H, Stengl G, Stein M, Federlin K: Analysis of proteins that
interact with the IL-2 regulatory region in patients with rheumatic
diseases. Clin Exp Immunol 1995, 99:325e330
40. Martin JE, Broen JC, Carmona FD, Teruel M, Simeon CP, Vonk MC,
et al: Identiﬁcation of CSK as a systemic sclerosis genetic risk factor
through genome wide association study follow-up. Hum Mol Genet
2012, 21:2825e2835
41. Kaufman CK, Fuchs E: It’s got you covered. NF-kappaB in the
epidermis. J Cell Biol 2000, 149:999e1004
42. Mizgerd JP, Lupa MM, Kogan MS, Warren HB, Kobzik L,
Topulos GP: Nuclear factor-kappaB p50 limits inﬂammation and
prevents lung injury during Escherichia coli pneumonia. Am J Respir
Crit Care Med 2003, 168:810e817
43. Fullard N, Wilson CL, Oakley F: Roles of c-Rel signalling in
inﬂammation and disease. Int J Biochem Cell Biol 2012, 44:851e860
44. Distler JH, Jüngel A, Kowal-Bielecka O, Michel BA, Gay RE,
Sprott H, Matucci-Cerinic M, Chilla M, Reich K, Kalden JR, Müller-
Ladner U, Lorenz HM, Gay S, Distler O: Expression of interleukin-21
receptor in epidermis from patients with systemic sclerosis. Arthritis
Rheum 2005, 52:856e864
45. Tian WZ, Liou HC: RNAi-mediated c-Rel silencing leads to apoptosis
of B cell tumor cells and suppresses antigenic immune response
in vivo. PLoS One 2009, 4:e5028
46. Hsu T, Mitragotri S: Delivery of siRNA and other macromolecules into
skin and cells using a peptide enhancer. Proc Natl Acad Sci USA 2011,
108:15816e15821
47. Hickerson RP, Flores MA, Leake D, Lara MF, Contag CH,
Leachman SA, Kaspar RL: Use of self-delivery siRNAs to inhibit gene
expression in an organotypic pachyonychia congenita model. J Invest
Dermatol 2011, 131:1037e1044ajp.amjpathol.org - The American Journal of Pathology
